Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Hot Flash Clinical Trials

A listing of Hot Flash medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (5) clinical trials

A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women

Hot flashes are the most common symptom of menopause and affect almost 75% of menopausal women. Clinical evidence indicates potent antagonists of 5-HT2A are more likely to cause hypothermia. Risperidone is a potent 5-HT2A and a dopamine D2 receptor antagonist and is proposed to have effect on reduciton of hot ...

Phase

Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

In this study, investigators aim to assess the effects of SGB on VMS, sympathetic nervous system activity, depression and sleep in Hispanic and Spanish-Speaking women with breast cancer on endocrine therapy who take tamoxifen, aromatase inhibitors (AIs) or SERMS, in a prospective, randomized, sham-controlled pilot study. Project Hypothesis: The frequency ...

Phase

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Vasomotor symptoms (hot flashes) are the most common complaint among women entering menopause and, for many women, may continue to occur for up to 5 years (although about 20% of women may have them for up to 15 years). Approximately 75% of peri-menopausal women will experience vasomotor symptoms, with 10% ...

Phase

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Hypotheses: The frequency and intensity of subjective and objective VMS will be significantly lower in women randomized to active SGB as compared to sham controls. Mood, memory, cognition, sleep, and quality of life will all be improved in the treatment group as compared to the sham-control group. Specific Goals and ...

Phase

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

There has been considerable interest in developing new treatment strategies for managing hot flashes among women with breast cancer, in view of the limitations associated with currently available treatments. This randomized study evaluates the safety and efficacy of 3 weeks of solifenacin compared to 3 weeks of clonidine, for women ...

Phase